2,3-Dimethoxypyridine

We are 2,3-Dimethoxypyridine CAS:52605-97-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,3-Dimethoxypyridine
CAS.NO:52605-97-7
Synonyms:2,3-Dimethoxypyridine
2,3-dimethoxy-pyridine
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 179.8±20.0 °C at 760 mmHg
Molecular Formula C7H9NO2
Molecular Weight 139.152
Flash Point 63.6±12.0 °C
 
Specification:
Appearance:Yellow Liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

2,3-Dimethoxypyridine


Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.6-Chlorooxindole The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.25360-10-5 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.4 – [(5-bromo-2-clorofenil) metil] fenol CAS:864070-18-8 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
1H-Imidazol-1-ylacetonitrile View Details
4-Fluorobenzonitrile View Details
Ethyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate View Details
4-Cyanophenylboronic Acid Cas:126747-14-6 manufacturer 4-Bromo-1-chloro-Dibenzofuran Cas:2183475-72-9 manufacturer 6-methylpyridin-2-amine manufacturer 2,6-Difluoro-4-hydroxybenzonitrile Cas:123843-57-2 manufacturer 1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropane-1-carbonitrile Cas:862574-87-6 manufacturer